GE HealthCare Technologie... (GEHC)
GE HealthCare Statistics
Share Statistics
GE HealthCare has 457.3M shares outstanding. The number of shares has increased by 0.33% in one year.
Shares Outstanding | 457.3M |
Shares Change (YoY) | 0.33% |
Shares Change (QoQ) | 0.05% |
Owned by Institutions (%) | 81.86% |
Shares Floating | 456.13M |
Failed to Deliver (FTD) Shares | 8 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 12.76M, so 2.79% of the outstanding shares have been sold short.
Short Interest | 12.76M |
Short % of Shares Out | 2.79% |
Short % of Float | 2.88% |
Short Ratio (days to cover) | 3.91 |
Valuation Ratios
The PE ratio is 17.89 and the forward PE ratio is 18.87. GE HealthCare's PEG ratio is 0.41.
PE Ratio | 17.89 |
Forward PE | 18.87 |
PS Ratio | 1.81 |
Forward PS | 1.7 |
PB Ratio | 4.22 |
P/FCF Ratio | 23 |
PEG Ratio | 0.41 |
Enterprise Valuation
GE HealthCare Technologies Inc. has an Enterprise Value (EV) of 42.55B.
EV / Earnings | 21.35 |
EV / Sales | 2.16 |
EV / EBITDA | 11.61 |
EV / EBIT | 16.21 |
EV / FCF | 27.45 |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.18.
Current Ratio | 0.88 |
Quick Ratio | 0.68 |
Debt / Equity | 0.18 |
Total Debt / Capitalization | 15.1 |
Cash Flow / Debt | 1.3 |
Interest Coverage | 5.2 |
Financial Efficiency
Return on equity (ROE) is 0.24% and return on capital (ROIC) is 20.57%.
Return on Equity (ROE) | 0.24% |
Return on Assets (ROA) | 0.06% |
Return on Capital (ROIC) | 20.57% |
Revenue Per Employee | 371.17K |
Profits Per Employee | 37.6K |
Employee Count | 53K |
Asset Turnover | 0.59 |
Inventory Turnover | 5.91 |
Taxes
Income Tax | 531M |
Effective Tax Rate | 0.21 |
Stock Price Statistics
The stock price has increased by -5.72% in the last 52 weeks. The beta is 1.33, so GE HealthCare's price volatility has been higher than the market average.
Beta | 1.33 |
52-Week Price Change | -5.72% |
50-Day Moving Average | 85.61 |
200-Day Moving Average | 84.1 |
Relative Strength Index (RSI) | 44.85 |
Average Volume (20 Days) | 2.85M |
Income Statement
In the last 12 months, GE HealthCare had revenue of 19.67B and earned 1.99B in profits. Earnings per share was 4.37.
Revenue | 19.67B |
Gross Profit | 8.21B |
Operating Income | 2.63B |
Net Income | 1.99B |
EBITDA | 3.67B |
EBIT | 2.63B |
Earnings Per Share (EPS) | 4.37 |
Balance Sheet
The company has 2.87B in cash and 1.5B in debt, giving a net cash position of 1.37B.
Cash & Cash Equivalents | 2.87B |
Total Debt | 1.5B |
Net Cash | 1.37B |
Retained Earnings | 3.26B |
Total Assets | 33.09B |
Working Capital | -1.16B |
Cash Flow
In the last 12 months, operating cash flow was 1.95B and capital expenditures -401M, giving a free cash flow of 1.55B.
Operating Cash Flow | 1.95B |
Capital Expenditures | -401M |
Free Cash Flow | 1.55B |
FCF Per Share | 3.4 |
Margins
Gross margin is 41.71%, with operating and profit margins of 13.34% and 10.13%.
Gross Margin | 41.71% |
Operating Margin | 13.34% |
Pretax Margin | 13.12% |
Profit Margin | 10.13% |
EBITDA Margin | 18.64% |
EBIT Margin | 13.34% |
FCF Margin | 7.88% |
Dividends & Yields
GEHC pays an annual dividend of $0.18, which amounts to a dividend yield of 0.15%.
Dividend Per Share | $0.18 |
Dividend Yield | 0.15% |
Dividend Growth (YoY) | 16.67% |
Payout Ratio | 4.26% |
Earnings Yield | 5% |
FCF Yield | 3.88% |
Analyst Forecast
The average price target for GEHC is $102, which is 16.7% higher than the current price. The consensus rating is "Buy".
Price Target | $102 |
Price Target Difference | 16.7% |
Analyst Consensus | Buy |
Analyst Count | 12 |
Scores
Altman Z-Score | 2.02 |
Piotroski F-Score | 5 |